5 More Biotech Secondaries Traders Are Watching

Below are five more biotech companies looking to raise money this week.

Puma Biotechnology PBYI is offering one million shares of stock.  The underwriters are Bank of America Merrill Lynch, J.P. Morgan, Leerink Partners, and Cowen.  The deal is expected to price Wednesday night and trade Thursday.

Versartis VSAR is offering $75 million of stock.  The underwriters are Citigroup, Credit Suisse, Cowen, Canaccord Genuity, and SunTrust Robinson Humphrey.  The deal is expected to price Wednesday night and trade Thursday.

Zafgen ZFGN is offering 2,840,909 shares of stock.  The underwriters are Leerink, Cowen, Canaccord, and JMP Securities.  The deal is expected to price Wednesday night and trade Thursday.

The company is expected to report Phase 3 results of Beloranib for Prader-Willi Syndrome in the fourth quarter.Vitae Pharmaceuticals VTAE is offering 3 million shares of stock.  The underwriters are Stifel, BMO Capital, Piper Jaffray, JMP Securities, and Wedbush.  The deal is expected to price Thursday night and trade Friday.

The company is expecting to report Phase 2 data of VTP-34072 for Type 2 diabetes in the first half of 2015.

Verastem VSTM is offering $40 million worth of stock.  The underwriters are Jefferies, Leerink Partners, Guggenheim, and Oppenheimer.  The deal is expected to price Thursday night and trade Friday.

Verastem is expected to announce an interim analysis for its Phase II trial of VS-6063 for mesothelioma in the second quarter.